Abstract:The methods currently used for the detection of ANA have been analyzed, with emphasis on their practical application to the diagnosis of the CTD. The use of the indirect IF-ANA test was recommended as a screening procedure to detect ANA. The need to standardize the technique using a single substrate and fluorescent conjugates with uniform F/P ratios was stressed. Most importantly, the value of titrating ANA for the diagnosis of the CTD was discussed. ANA titers higher than 1/500 are usually very significant clinically, often found in spontaneous or drug-induced SLE and few other CTD. The immunologic aspects of ANA and their potential value as aids in the diagnosis and management of the CTD were discussed. Anti-nDNA antibodies have been found to have a high degree of specificity for SLE and high titers of these antibodies correlate well with low levels of serum complement and severity of kidney involvement. The spectrum of ANA in the sera from patients with SLE has been expanded with the finding of anti-Sm antibodies which, when detected by gel precipitation with prototype serum, have been found so far only in SLE. Some of these antibodies have been found to have prognostic significance. Patients with MCTD and a group of patients with SLE have high titers of serum ANA with specificity for an RNase-sensitive component of ENA. The group of SLE patients defined by the presence of these antibodies (anti-Mo) have a better prognosis and in general develop only mild nephritis or have no kidney involvement at all. High titers of pure antinucleolar antibodies probably are found almost exclusively in the sera of patients with scleroderma. Some ANA have organ specificity, and GS-ANA have been found in all patients with Felty's syndrome and in a large proportion of patients with RA. One of the great advances in the field has been the recognition that ANA can be induced in the human and in experimental animals by the use of a number of therapeutic agents. Some of these agents can also induce a clinical picture resembling spontaneous SLE, though kidney involvement does not occur or is extremely mild. It is interesting that the whole spectrum of ANA can be found in drug-induced LE except anti-nDNA antibodies which have been associated to the pathogenesis of immune complex nephritis in spontaneous SLE. There is no doubt that research on ANA has contributed a great deal to the understanding of the CTD and will continue to be a valuable tool for the clinician and the investigator.

Analysis of Immunogenicity of ENA in Activated Lymphocytes

Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus

Effect of ALD-DNA Derived from Cells with Different Apoptotic Levels on the Induction of Anti-Double-stranded DNA Antibody

Induction of Systemic Lupus Erythematosus-Like Syndrome in Syngeneic Mice by Immunization with Activated Lymphocyte-Derived DNA

Role of Anti-Nucleosome Antibody in the Diagnosis of Systemic Lupus Erythematosus

Antinuclear antibodies (ANA): immunologic and clinical significance

Analysis of combined dectection of ANA,ENA and dsDNA in 173 Systemic Lupus Erythematosus patients

Induction of Systemic Lupus Erythematosus Syndrome in Balb/C Mice by Immunization with Active Chromatin

Association Analysis Etween Anti-nucleosome Antibodies: with Clinical Features and Disease Activity in Systemic Lupus Erythematosus of Chinese Han

Epidermal nuclear immunoglobulin deposits in some connective tissue diseases: correlation with ENA antibodies.

[Detection of anti-nuclear antibodies in liver diseases by indirect immunofluorescence method and enzyme-linked immunosorbent assay]

Analysis of the Cellular Mechanism Underlying Inhibition of EAE after Treatment with Anti-Nkg2a F(ab′)2

Induction and Characteristics of Systemic Lupus Erythematous Syndrome in Mice

Antibodies against neutrophil extracellular traps (NETs) potentiate clinical performance of anti-double-stranded DNA antibodies in systemic lupus erythematosus

Analysis of Immunity Index and Immunopathogenesis Pattern of Lupus Nephritis Patients

[Specific antibodies of soluble nuclear antigens in autoimmune vasculitis]

Detection of anti-neutrophilic cytoplasmic total antibodies by indirect ELISA and demonstration of its clinical significance

Antineutrophil Cytoplasmic Autoantibodies (ANCA) and Their Target Antigens in Chinese Patients with Lupus Nephritis

Production of Anti-Double-stranded DNA Antibodies in Activated Lymphocyte Derived DNA Induced Lupus Model Was Dependent on CD4+T Cells

Enzyme immunoassays for antinuclear antibodies

Antilymphocyte Antibodies in Systemic Lupus Erythematosus: Association with Disease Activity and Lymphopenia.